Superior T-cell immunity in COVID vaccinated
A recent study published in the journal Public Library of Science (PLOS) ONE presented the T cell and humoral immune responses following severe acute respiratory syndrome coronavirus...
ACE2
-
-
Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses
In a recent study posted to the bioRxiv* preprint server, researchers assessed the binding pocket of linoleic acid (LA), an essential free-fatty acid (FFA) in...
-
Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins
In a recent study posted to the bioRxiv* preprint server, researchers identified a nanobody that inhibits severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants. Study: Peptide...
-
A novel mouse model to test SARS-CoV-2 viral infection
In a recent study posted to the Research Square* preprint server, researchers developed a novel mouse model for testing infection by severe acute respiratory syndrome...
-
Scientists discover how SARS-CoV-2 activates platelets
In a recent study published in the Blood Advances journal, the researchers assessed the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on platelet...
-
The challenges of Omicron
The coronavirus disease 2019 (COVID-19) pandemic broke out early in 2020, following the reporting of several cases of pneumonia caused by the severe acute respiratory...
-
Marine resources could be promising drug candidates against SARS-CoV-2 Omicron
A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus...
-
Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients
In a recently published article in the journal Cancer Cell, scientists have demonstrated the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in...
-
Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious
In a recent study posted to the bioRxiv* preprint server, the researchers compared the efficiency of monovalent and bivalent messenger ribonucleic acid (mRNA) vaccines against...
-
Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants
As of April 21, 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19), has infected over 507 million...
-
Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections
In a recent study posted to the medRxiv* preprint server, the researchers investigated the effect of binding antibodies on severe acute respiratory syndrome coronavirus 2...
-
Evolution of SARS-CoV-2 variants
A recent article published in Cold Spring Harbor Perspectives in Medicine has demonstrated the evolutionary process and biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),...